← All organizations

Innovation Fund Denmark

Academic/HospitalWebsite ↗

Also known as: Innovation Fund Denmark

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 1, 2022

Timeline

2010s

Jan 1, 2014
Innovation Fund Denmark— Founded

Drugs by trial phase (12 distinct, 11 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

iloprost

Phase 1 (1 own, 0 via acquisition)

lidocaine

Other trials (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT04702672CollaboratorN/AJun 1, 2022
NCT06165393CollaboratorN/AMay 11, 2022
NCT04885946CollaboratorN/AApr 21, 2021
NCT04646746CollaboratorN/AFeb 8, 2021
NCT04563325CollaboratorPhase 4Sep 15, 2020
NCT04550078CollaboratorN/AJul 22, 2020
NCT04123444CollaboratorPhase 2/Phase 3Oct 28, 2019
NCT03372304CollaboratorPhase 4Nov 29, 2017
NCT03310047CollaboratorPhase 1Oct 30, 2017
NCT03326609CollaboratorPhase 4Oct 4, 2017
NCT02829697CollaboratorPhase 4Jul 1, 2016

Details

Founded: Aarhus, DK Jan 1, 2014
Last known activity: Jun 1, 2022